RSS

Advanced Search

Printed From BioPortfolio.com

+ News Categories + Corporate Categories + Report Categories

News

Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors.

Search Articles

Showing News Articles 1–25 of 2362

Last Hour Last 24 Hours May 2012 Apr 2012 Mar 2012 Feb 2012 Jan 2012 Dec 2011 Advanced Search

Order

Date Published

Source

Keyword

* Minimum 4 characters

or Cancel

Sat 26 May 2012

Canadian research team makes safe iPS cells by the millionsUniversity of Calgary researchers Derrick Rancourt, PhD, and Roman Krawetz, PhD, have perfected a new bioreactor technology that allows them to make millions of pluripotent stem cells much more quickly than ever before. “The even better news is, we...

Fri 25 May 2012

FDA’s public hearing on biosimilars draft guidancesOn 11 May 2012, FDA held a public hearing to gain input on their draft guidances relating to the development of biosimilar products and it seems that the guidances were generally well accepted.

Increased use of generic statins proves cost effective in AustraliaA recent study concluded that closing the statin ‘treatment gap’ using generics was cost-effective in the secondary prevention of coronary artery disease (CAD) in Australia [1].

Immunogenicity of biologicalsThis article discusses the issue of immunogenicity with respect to originator biologicals and biosimilars was raised [1].

Generics makers cannot gain access to some brand-name drugsGenerics manufacturers trying to create generics for certain drugs are having problems gaining access to samples of the brand-name drugs due to restrictions on supply put in place by FDA.

APPG reports on drug shortages and MHRA bans unlicensed stock tradingOn 14 May 2012, the All-Party Pharmacy Group (APPG) published the results of its inquiry into drug shortages in the UK. In response to this the Medicines and Healthcare products Regulatory Agency (MHRA) has decided to ban unlicensed stock trading by...

Steirischer Kren macht aktive Enzyme sichtbarBiokatalysatoren kommen immer öfter beim Herstellen von Pharmazeutika zum Einsatz. Das Austrian Centre of Industrial Biotechnology forscht an der Herstellung von Transaminasen im großen Stil und kann deren Aktivität mit einem neuen Testverfahren s...

HIGH-TECH DIAGNOSETOOLS AUS ÖSTERREICH SIND EUROPAREIFRisikokapitalgeber tecnet unterstützt Anagnostics´ Technologie zur In-vitro-Diagnostik St. Pölten / St. Valentin, 24. Mai 2012 – Ob Drogen im Urin oder Mutationen in tumor-relevanten Genen – mit einer neu entwickelten Diagnosemethode s...

SANOCHEMIA im Halbjahr weiter in der GewinnzoneInformation für unsere Kapitalanleger und Institutionelle Investoren Halbjahresbericht (01. Oktober 2011 – 31. März 2012) Sanochemia weiter in der Gewinnzone: leichter Umsatzanstieg Gewinn je Aktie Euro 0,03 wirtschaftliche Rahmenbedingungen und...

Generics sustainability to be investigated by UK DoH and industryThe British Generic Manufacturers Association (BGMA) and the UK Department of Health (DoH) have agreed to work together to investigate potential challenges to the sustainability of the generics industry in the UK.

US Senator calls for prizes not patents for drug discoveryA radical idea has been proposed by a US Senator calling for patents on drugs to be scrapped and instead an annual prize fund set up, which would reward the discovery of new treatments. These treatments would then, due to competition, become availabl...

World Biosimilars Congress 2012Strategies for navigating the regulatory, manufacturing, sales and marketing route to biosimilars market entry

Nachwuchsforscher vom Biozentrum Innsbruck erhält Österreichischen Mikrobiologie Preis 2012Mario Gründlinger von der Sektion für Molekularbiologie des Biozentrums der Medizinischen Universität Innsbruck erhielt am 23. Mai den Österreichischen Mikrobiologie Preis 2012. Die Österreichische Gesellschaft für Hygiene, Mikrobiologie und Pr...

Zytoprotec schließt Phase I/II-Studie mit innovativem Dialyseprodukt erfolgreich abVerhandlungen mit weltweitem Pharmaunternehmen Wien, 23. Mai 2012 – Die Wiener Zytoprotec hat die Phase I/II-Studie mit PD-protec™ erfolgreich abgeschlossen, wie das Unternehmen heute mitteilte. PD-protec™ ist eine neuartige Dialyse-Flüssigkei...

Thu 24 May 2012

Thioridazine destroys human cancer stem cells but not healthy onesA team of scientists at McMaster University has discovered that the drug thioridazine successfully kills cancer stem cells in humans while avoiding the toxic side-effects of chemotherapy and radiation. “The unusual aspect of our finding is the...

Fountain of Youth for Stem CellsResearchers at the Salk Institute for Biological Studies have uncovered a series of biological events that implicate the stem cells’ surroundings, known as their “niche,” as the culprit in loss of stem cells due to aging. Their find...

Encoding, Storing and Erasing Data within the DNA of Living Cells“It took us three years and 750 tries to make it work, but we finally did it,” said Jerome Bonnet, PhD, of his latest research, Rewritable digital data storage in live cells via engineered control of recombination directionality, which describes�...

Heilen mit Zellen: Internationales Netzwerk gegründetSechs Translationszentren gründen die "Regenerative Medicine Coalition" / Staatssekretär Braun:...

Scienion offers new sciFLEXARRAYER S1 model for Applications in Research LabsScienion launches the new version of its sciFLEXARRAYER S1 at European Lab Automation in Hamburg,...

In study by the Broad Institute and Massachusetts General, new clues about cancer cell metabolism emergeFor almost a century, researchers have known that cancer cells have peculiar appetites, devouring glucose in ways that normal cells do not. But glucose uptake may tell only part of cancer’s metabolic story. Researchers from the Broad Institute and...

Harvard study finds modeling gene-gene and gene-environment interaction may not substantially improve risk predictionHarvard School of Public Health (HSPH) researchers have found that detailed knowledge about your genetic makeup—the interplay between genetic variants and other genetic variants, or between genetic variants and environmental risk factors—may only...

Max Planck Florida Institute says Sensory Experience is Good for the Aging BrainDespite a long-held scientific belief that much of the neural circuitry is fixed by the time of adolescence, a new study shows that changes in sensory experience can cause massive rewiring of the brain, even as one ages. In addition, the study found...

$97 million expansion for Mayo ClinicMayo Clinic will invest about $97 million in two new major Jacksonville construction projects scheduled to begin this summer. The projects include the addition of two floors and 90 beds to its hospital, and the construction of an off-site primary car...

UvA physicist wins Science & Innovation AwardMay 23, 2012 - Katerina Dohnalova, a researcher at the Institute of Physics of the University of Amsterdam (UvA), has won the Amsterdam Science & Innovation Award 2012. She will receive a prize worth 5000 euros. Dohnalova has developed a silicon nano...

UF offers biotechnology industry short-course June 4-7UF offers Core Concepts in Biomanufacturing and Quality Systems: Designed for the development of skills required for success in today’s biotechnology industry, this course covers two tracks: “Processes & Facilities” and “Regulatory Af...

0 1 2 3 4 ›»